Table 3.
Adjusted multivariate analysis investigating the association between interventional telemonitoring (ITM) and unplanned hospitalization compared to other study groups.
| ORa | 95% CI | P-value | |
|---|---|---|---|
| Age | 0.991 | (0.970–1.012) | 0.383 |
| Hypertension | 1.153 | (0.691–1.922) | 0.586 |
| Diabetes mellitus | 1.286 | (0.741–2.234) | 0.371 |
| Ischemic-HF | 1.144 | (0.693–1.889) | 0.599 |
| LVEF | 0.989 | (0.967–1.011) | 0.336 |
| Ivabradine use | 0.456 | (0.173–1.200) | 0.112 |
| (ACEi, ARB, ARNIs) | 0.544 | (0.298–0.994) | 0.048 |
| Ambulatory process | 0.969 | (0.360–2.610) | 0.950 |
| Groups | |||
| -STM-group | 0.862 | (0.472–1.574) | 0.629 |
| -ITM-group | 0.303 | (0.165–0.555) | <0.001 |
STM-group, standard telemonitoring-group; ITM-group, interventional telemonitoring group; BMI, body mass index; HF, heart failure; LVEF, left ventricular ejection fraction; ACEi, Angiotensin converting enzyme inhibitor; ARB: Angiotensinogen 2 receptor antagonist; ARNIs: Angiotensin receptor-neprilysin inhibitors; ORa, adjusted odds ratios.